Vector Remote Care: Study Finds Remote Cardiac Monitoring Programs Significantly More Successful When Patients, Not Devices, Are Primary Focus

Vector Remote Care today announced the results of a survey on the adoption of remote cardiac monitoring solutions and their impact on managing heart disease in the U.S.

The findings reveal that remote cardiac monitoring (RCM) programs that focus on just remote device data management are missing out on both clinical and financial benefits. In comparison, cardiology practices taking a patient-centric approach focused on data and patient compliance, report improved clinical and financial outcomes.

The survey of over 110 respondents with various roles within a cardiology practice shows nearly 75 percent of respondents believe improving patient outcomes is the first or second priority for their monitoring program.

Nevertheless, narrowing the scope to physician respondents, 43 percent revealed that only 20 percent or less of their heart disease patients are connected (and result in billable reports), which indicates a large margin of missed opportunities for improved clinical and financial outcomes. Despite less-than-optimal connection rates, a strong majority of total respondents—68.75 percent— rate their program as good or excellent.

According to Kristin Stitt, DNP, APRN, Chief Clinical Officer at Vector, “These numbers are not surprising, as RCM is still relatively new. Strong satisfaction with a program that has low connection rates indicates that many practices focus on getting the devices up and running, but are not fully aware of what is possible when you design your program around patient care.”

While 93.52 percent of respondents are doing remote monitoring for rhythm management, about one-third of those practices have less than 60 percent of their patients regularly connected. In addition, fewer than 68 percent of respondents are monitoring for heart failure, and fewer than 19 percent are monitoring for hypertension.

Programs with 80-100 percent of their patients connected are most successful at gathering the revenue needed to cover program costs. Practices with less than 60 percent of patients routinely connected for billable reports clearly see covering costs as a significant challenge.

Electrophysiologist Christopher Porterfield, MD, states, “There are hundreds to thousands of stories where remote monitoring has made it easier to care for patients and, in many cases, to save lives.” Dr. Porterfield assisted with survey development and analysis of the responses.

Additional findings show practices struggle to keep patients engaged in their care, placing a strain on staff and making it impossible for clinical and financial benefits to be fully realized. All respondents view keeping patients connected, reviewing alerts, and preparing reports as their biggest challenges, but practices’ staff doing the monitoring are the most burdened.

Respondents partnering with a third-party vendor cite improved satisfaction in being able to offload time-consuming administrative work. Third party success in enrolling patients, keeping them connected, and collecting appropriate revenue is likely due to a combination of clear goals, streamlined workflows, technology, and support services that ease burdens listed above.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”